tiprankstipranks
Sight Sciences sees Q4 revenue $18.9M-19.1M, consensus $20.29M
PremiumThe FlySight Sciences sees Q4 revenue $18.9M-19.1M, consensus $20.29M
2M ago
Sight Sciences study demonstrates benefits of OMNI system for managing POAG
Premium
The Fly
Sight Sciences study demonstrates benefits of OMNI system for managing POAG
2M ago
Sight Sciences does BIA of TearCare to treat MGD-associated DED in US
Premium
The Fly
Sight Sciences does BIA of TearCare to treat MGD-associated DED in US
2M ago
Sight Sciences price target lowered to $5.50 from $6 at Piper Sandler
PremiumThe FlySight Sciences price target lowered to $5.50 from $6 at Piper Sandler
4M ago
Sight Sciences Reports Modest Growth and Optimistic Outlook
Premium
Company Announcements
Sight Sciences Reports Modest Growth and Optimistic Outlook
4M ago
Sight Sciences backs FY24 revenue view, sees operating expenses down 4%-6%
Premium
The Fly
Sight Sciences backs FY24 revenue view, sees operating expenses down 4%-6%
4M ago
Noridian final LCD positive for Sight Sciences, says Lake Street
PremiumThe FlyNoridian final LCD positive for Sight Sciences, says Lake Street
5M ago
AmEx downgraded, Texas Instruments upgraded: Wall Street’s top analyst calls
Premium
The Fly
AmEx downgraded, Texas Instruments upgraded: Wall Street’s top analyst calls
7M ago
Sight Sciences initiated with a Buy at Lake Street
Premium
The Fly
Sight Sciences initiated with a Buy at Lake Street
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100